SIRT1 and primary cutaneous T-cell non-Hodgkin lymphoma: In the context of cutaneous T-cell lymphoma (CTCL), our observation that SIRT1 inhibition induces cell growth arrest and apoptosis corroborates previous work highlighting its potential role in controlling immune cell proliferation and infiltration.